With 4.33 million shares changed hands, the volume of the stock remained lighter than its average volume of 6.23 million shares. During the session, the Uranium company that operates in wider Energy sector, reached to the highest price of $7.5 whereas the lowest price it dropped to was $7.33. The 52-week range on NXE shows that it touched its highest point at $8.96 and its lowest point at $4.95 during that stretch. It currently has a 1-year price target of $10.22. Beta for the stock currently stands at 1.93.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Three-month performance surged to 29.93% while six-month performance rose 4.83%. The stock gained 6.19% in the past year, while it has gained 5.43% so far this year. A look at the trailing 12-month EPS for NXE yields 0.17 with Next year EPS estimates of -0.10. For the next quarter, that number is -0.03. This implies an EPS growth rate of -144.30% for this year and -99.09% for next year.
Float and Shares Shorts:
At present, 565.00 million NXE shares are outstanding with a float of 517.40 million shares on hand for trading. On 2024-11-29, short shares totaled 52.74 million, which was 934.0 higher than short shares on 1730332800. In addition to Mr. Leigh Robert Curyer ACA, BA (Acc) as the firm’s Founder, President, CEO & Director, Mr. Benjamin Salter serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.53104 of NXE’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, NXE reported revenue of $0.0 and operating income of -$18712000.0. The EBITDA in the recently reported quarter was -$10496000.0 and diluted EPS was $0.02.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NXE since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of -$0.05625126 being high and -$0.11251 being low. For NXE, this leads to a yearly average estimate of -$0.07031407. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
